AzTrials
AzTrials

InterventionNCT06515574

Effect of Developmental Care on Very Low Birth Weight Infants

A study testing developmental care in people with Intervention, run by Children's Hospital of Fudan University at 2 sites in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn if developmental care works when implemented in very low birth weight infants. The main questions it aims to answer are: Does developmental care shorten the length of hospital stay in the very low birth weight infants? Does developmental care increase the opportunity of… Read more about this study

Who is it for?
Ages 0 to 30 days
Conditions the study is for
Intervention
What is being tested?
developmental care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,600 participants
Where
2 sitesChina
Study dates
30 Aug 2024to 1 Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 0 to 30 days
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Birth weights less than 1500 g
  • Admitted or transported to a level III NICU within 24h of birth
  • OI>30

Who cannot join

  • Severe congenital malformations
  • various chromosomal disorders
  • genetic metabolic diseases,
  • severe neurological disorders

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

China2 sites, 2 recruiting
  • Children's hospital of Fudan university

    Shanghai, Shanghai / 上海, 201102

    LYU tianchan, 02164935075, lvtianchan1988@aliyun.com

    Recruiting
  • Children's Hospital of Fudan University

    Shanghai, Shanghai Municipality, 200032

    Xiaojing Hu, PhD, 18017590869, humama2015@126.com

    Not yet recruiting

Other trials in China

About this study

Official title: Effect of Developmental Care on Very Low Birth Weight Infants: a Stepped-wedge Cluster Randomised Trial

The goal of this clinical trial is to learn if developmental care works when implemented in very low birth weight infants. The main questions it aims to answer are:

  • Does developmental care shorten the length of hospital stay in the very low birth weight infants?
  • Does developmental care increase the opportunity of family centered care in the very low birth weight infants? The clinical trial will use a 36-month stepped-wedge cluster-randomised trial conducted across 40 Neonatal intensive care units . A developmental care bundle will be tailored to meet the identified needs of participating NICUs.
Read the detailed description

Developmental care in the NICU focuses on creating a nurturing environment that supports the physical, emotional, and developmental needs of premature infants. This approach includes strategies like minimizing unnecessary noise and light, ensuring appropriate positioning and handling of infants, promoting skin-to-skin contact, and facilitating parental involvement in care.

The clinical trial investigates the effectiveness of developmental care in very low birth weight (VLBW) infants. The primary objectives are to determine whether developmental care can (1) reduce the length of hospital stay and (2) enhance the opportunity for family-centered care in these infants. The study employs a 36-month stepped-wedge cluster-randomised trial design, involving 40 Neonatal Intensive Care Units (NICUs).

In this trial, all NICUs will eventually receive the intervention, but the order in which they start implementing the developmental care bundle will be randomized. This approach allows each NICU to serve as its own control, comparing outcomes before and after the intervention.

Data collection will occur at multiple time points before and after the implementation of the developmental care bundle, enabling a comprehensive analysis of its impact. By tailoring interventions to each NICU's specific context and needs, the study aims to generate robust evidence on the benefits of developmental care for VLBW infants and their families.

Conditions
Intervention
Being tested
developmental care
Keywords
developmental care

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • developmental careBehavioural

    Individualized Developmental Care that includes the light, noise, sleep, etc.

Study groups in NCT06515574
Study groupRoleWhat they receive
Developmental careExperimentalIn stage 1, participant in this arm will receive the developmental care
Receives: Behavioral: developmental care
Usual careNo interventionParticipant in this arm will receive the usual care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Length of hospital stay

    Length of hospital stay (in days)

    Measured: From the day admitted into the NICU until day on discharge, generally assessed up to 1 year

Secondary outcomes (1)
  1. Skin to skin care duration

    Skin-to-skin care, also known as kangaroo care, involves placing a newborn baby directly on a parent's bare chest. Record the duration of skin to skin care every day during the hospitalization by hours

    Measured: From the day admitted into the NICU until day on discharge, generally assessed up to 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Jul 2024
  2. Study start30 Aug 2024
  3. Primary completion30 Aug 2028 (estimated)
  4. Study completion1 Dec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Sequential
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
1,600 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06515574
Sponsor's protocol ID
20240610
Status last verified
Oct 2026
First submitted
10 Jul 2024
Last updated
26 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Unidentified individual participant data (including data dictionaries) will be made available, in addition to study protocols, the statistical analysis plan, the informed consent form and the related code. The data will be made available upon publication to researchers who provide a methodologically sound proposal for use in achieving the goals of the approved proposal. Proposals should be submitted to corresponding authors.

Questions about this trial

What is this clinical trial studying?

A study testing developmental care in people with Intervention, run by Children's Hospital of Fudan University at 2 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 26 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Lyu Tianchan (18017590870, lvtianchan1988@aliyun.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Length of hospital stay (time frame: From the day admitted into the NICU until day on discharge, generally assessed up to 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2026; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in